Section of Neonatal Medicine, Imperial College London, London, UK.
School of Medicine, Imperial College London, London, London, UK.
Arch Dis Child Fetal Neonatal Ed. 2020 Jan;105(1):69-75. doi: 10.1136/archdischild-2019-316823. Epub 2019 May 13.
Inconsistent outcome selection and reporting in clinical trials are important sources of research waste; it is not known how common this problem is in neonatal trials. Our objective was to determine whether large clinical trials involving infants receiving neonatal care report a consistent set of outcomes, how composite outcomes are used and whether parents or former patients were involved in outcome selection.
A literature search of CENTRAL, CINAHL, EMBASE and MEDLINE was conducted; randomised trials published between 1 July 2012 and 1 July 2017 and involving at least 100 infants in each arm were included. Outcomes and outcome measures were extracted and categorised by physiological system; reported former patient and parent involvement in outcome selection was extracted.
Seventy-six trials involving 43 126 infants were identified; 216 different outcomes with 889 different outcome measures were reported. Outcome reporting covered all physiological systems but was variable between individual trials: only 67/76 (88%) of trials reported survival and 639 outcome measures were only reported in a single trial. Thirty-three composite outcomes were used in 41 trials. No trials reported former patient or parent involvement in outcome selection.
Inconsistent outcome reporting and a lack of parent and former patient involvement in outcome selection in neonatal clinical trials limits the ability of such trials to answer clinically meaningful questions. Developing and implementing a core outcome set for future neonatal trials, with input from all stakeholders, should address these issues.
临床试验中结果选择和报告的不一致是研究浪费的重要来源;目前尚不清楚这一问题在新生儿试验中有多普遍。我们的目的是确定涉及接受新生儿护理的婴儿的大型临床试验是否报告了一组一致的结果,复合结果的使用情况以及父母或前患者是否参与了结果选择。
对 CENTRAL、CINAHL、EMBASE 和 MEDLINE 进行文献检索;纳入 2012 年 7 月 1 日至 2017 年 7 月 1 日期间发表的、每臂至少纳入 100 名婴儿的随机试验。提取并按生理系统分类结果和结局测量指标;提取报告的前患者和家长参与结局选择的情况。
确定了 76 项涉及 43126 名婴儿的试验;报告了 216 个不同的结果和 889 个不同的结局测量指标。结果报告涵盖了所有生理系统,但在个别试验之间存在差异:只有 76/76(88%)的试验报告了生存率,639 个结局测量指标仅在单个试验中报告。41 项试验中使用了 33 个复合结局。没有试验报告前患者或家长参与结局选择。
新生儿临床试验中结果报告不一致且缺乏家长和前患者参与结局选择,限制了这些试验回答有临床意义问题的能力。未来的新生儿试验应制定和实施一个包含所有利益相关者投入的核心结局集,以解决这些问题。